All of the lower alkyl methacrylates are high production chemicals with potential for human exposure. The genotoxicity of seven mono-functional alkyl esters of methacrylic acid, i.e. methyl methacrylate, ethyl methacrylate, hydroxyethyl methacrylate, n-, i-and t-butyl methacrylate and 2 ethyl hexyl methacrylate, as well as methacrylic acid itself, the acyl component common to all, is reviewed and compared with the lack of carcinogenicity of methyl methacrylate, the representative member of the series so evaluated. Also reviewed are the similarity of structure, chemical and biological reactivity, metabolism and common metabolic products of this group of compounds which allows a category approach for assessing genotoxicity. As a class, the lower alkyl methacrylates are universally negative for gene mutations in prokaryotes but do exhibit high dose clastogenicity in mammalian cells in vitro. There is no convincing evidence that these compounds induce genotoxic effects in vivo in either submammalian or mammalian species. This dichotomy of effects can be explained by the potential genotoxic intermediates generated in vitro. This genotoxic profile of the lower alkyl methacrylates is consistent with the lack of carcinogenicity of methyl methacrylate.
1. Introduction
Human exposures
Methacrylic acid (MAA) and the lower alkyl methacrylates are high production volume chemicals (OECD, 2007) . As such, there is potential for human exposures with the attendant concerns for health effects. Although the production industries employ closed systems to minimize worker exposures, these can occur, not only in production workers but also in those engaged in the use of finished products (industrial, professional and consumer). Industry air levels have been reported to range from less than 5 up to 130 ppm (8 h time weighted average [TWA] ) (ECETOC, 1995) .
Methacrylates in methacrylate-based consumer products used in the application industries, health professions and by individuals are in the form of stable polymers that do not break down to constituent monomers. However, non-polymerized monomers may accompany the polymers to expose humans, either by inhalation if volatile or on contact. Most human exposure to the methacrylate esters will be by inhalation of vapors although dermal exposure is possible. The latter is of particular concern in dental or health workers as the protective gloves may not exclude the monomers (Zeiger et al., 1987; EU, 2002) and references therein).
Industrial applications of methacrylate polymers in addition to production include use in acrylic sheeting, resins incorporated in many products, paints, industrial coatings and finishes, adhesives, sealants, leather and paper coatings, inks and floor and textile finishes (Zeiger et al., 1987; Jones, 2002) . Personal uses of these materials may also result in exposure to contaminant monomers.
Methacrylates also find applications in dental prostheses and surgical bone cements, especially 2-hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA), where exposures may be external or internal (Zeiger et al., 1987) . Several studies have reported levels of external exposures to the health-care workers themselves (Zeiger et al., 1987; EU, 2002) and references therein). For example, MMA concentrations of 50e100 ppm have been measured in the breathing zone of surgeons during hip surgery, although only for short periods of time (Darre et al., 1992) . Patients in whom prostheses are being implanted are also exposed internally to contaminant monomers that may leach from the polymers. Blood levels of MMA have been measured in patients up to 60 min post-surgery, with the highest levels (~1.5 mg/ml ¼ 15 mM) occurring in the first 10 min (Pfaffli and Svartling, 1985) . Methacrylate monomers are also released from dental materials used in restorations (Zeiger et al., 1987; EU, 2002) and references therein) and can diffuse into the pulp space of teeth and even be detected in saliva, but only for a short period, after dental restoration (Gerzina and Hume, 1996; Michelsen et al., 2012) .
MMA is the highest volume chemical of the lower methacrylates in use for the production of polymers. It is also the most volatile of the methacrylate esters in this group, with human occupational exposure being primarily by inhalation. By contrast, methacrylates containing longer C-chain esters may not be sufficiently volatile to produce high inhalation exposures.
Absorption, distribution and metabolic detoxification
The absorption, distribution and metabolic detoxification have been extensively studied for MMA and MAA (EU, 2002 , EU, 2002a , These findings are considered to apply across the category of short chain alkyl esters of MMA considered in this review (OECD, 2004) .
MAA and its short chain alkyl esters are rapidly absorbed after inhalation, dermal or oral exposures in both humans and experimental animals (EU, 2002; Jones, 2002; EU, 2002a) and references therein). Following inhalation and dermal absorption, primary metabolism occurs in the tissues of initial contact, i.e. nasal epithelia or skin. However, following oral absorption, although much of the primary metabolism also occurs at the site of contact tissue (i.e. intestinal epithelial cells), some occurs in blood and liver. Following i.v. administration, the alkyl esters are eliminated by first pass through the liver in animals with a half-time elimination proportional to C-chain length of the ester e.g. 4.4 min for MMA and 23.8 min for 2-ethylhexyl methacrylate (EHMA) as demonstrated by PBPK modeling (Jones, 2002) . Although 99% of the i.v. administered esters are eliminated by first pass through the liver, the initial and subsequent time course for removal differ, with the former being the more rapid (Jones, 2002) . This reflects distribution to fat, which is metabolically inert and slowly releases the ester. Distribution to fat is proportional to chain length, with HEMA being uniquely lipophilic.
Attention has recently been given to HEMA in the dental literature where its clearance and distribution have been studied in guinea pigs and mice (Zeiger, 1990; Durner et al., 2009) . 20 mM/kg radiolabeled HEMA administered i.v. or by gastric tube to guinea pigs was cleared rapidly (24 h) with the major route being exhaled CO2 (Zeiger, 1990) . Intestinal elimination accounted for approximately 12% of the administered dose. Systemic distribution was later determined in male ICR(CD-1) mice following sub-cutaneous or gastric tube administration of 20 mM/kg radiolabeled material (Durner et al., 2009 ). After rapid uptake by both routes, most of the radiolabeled HEMA was excreted within one day as CO2. Radioactive HEMA was broadly distributed to all tissues. Although the highest concentrations in blood and tissues occurred in the first five minutes, after 24 h the tissue concentrations were in the nM range e thousand-to million-fold below cytotoxic concentrations when determined in vitro.
The primary detoxification pathway of the alkyl ester methacrylates is carboxylesterase mediated hydrolysis that yields the constituent MAA and alcohol components (Corkill et al., 1976; Bratt and Hathway, 1977; McCarthy and Witz, 1991; (Fig. 1 , Table 2 ). The carboxylesterases are non-specific, hydrolyze a variety of esters and are widely distributed in the tissues and organs of the body, including nasal epithelia and skin (sites of contact for inhalation and dermal exposures, respectively), GI tract epithelia (site of contact for oral exposure), blood and liver. It is of note that the carboxylesterase activity of human nasal epithelia is several fold lower than in rodents, an apparent reason for less nasal toxicity in humans than in the animals (Mainwaring et al., 2001 ).
The alkyl methacrylate esters have also been shown to conjugate with glutathione (GSH) in vitro, suggesting a potential alternate pathway for primary detoxification (McCarthy and Witz, 1991; McCarthy et al., 1994) . HEMA forms conjugates with GSH in vitro in human gingival fibroblasts or erythrocytes (or in the culture medium) when exposed at mM concentrations (4.0 mM) (Nocca et al., 2011) . However, this is only a high concentration reaction and is unlikely to be generally important in vivo.
An additional pathway for the primary metabolism of the alkyl methacrylate esters, i.e. epoxidation, is theoretically possible based on structure of its acyl MAA component. This requires sufficient parent compound stability to hydrolysis for the P450 mediated epoxidation to occur. Studies comparing MMA and HEMA have shown that for the former, hydrolysis is sufficiently rapid to disallow the possibility of epoxidation (Seiss et al., 2009 ). However, that was not the case for HEMA where hydrolysis was approximately 1000-fold slower, leading to sufficient amount of the parent compound for the epoxidation reaction. This presumably would be true also for other longer C-chain or branched chain alkyl methacrylate esters.
The primary detoxification products of the alkyl methacrylate esters, i.e., MAA and corresponding alcohol, also undergo secondary metabolism that does involve epoxidation. This too has been recently explored in the dental literature. Studies in HEMA exposed A549 human lung cells have demonstrated that these secondary metabolic steps proceed by one of two pathways (Durner et al., 2010) . One follows the valine pathway of amino-acid metabolism, producing L-malate through pyruvate metabolism after several steps with final production of CO2. The second is an epoxidation pathway that produces either monooxygenase mediated 2,3-epoxy MAA or dioxygenase mediated 2,3-epodioxy-MAA. Both oxygenase mediated reactions also produce formaldehyde. Final metabolism of these two epoxides eventually yields CO2. When A549 cells were exposed to 20 mM HEMA with a trace of radiolabeled material for differing time intervals up to 6.0 h, 60e75% of the MAA metabolism depending on time of assay proceeded via epoxidation (Durner et al., 2010) .
In addition to direct products of alkyl methacrylate metabolism, there are indirect products. Recent studies in human gingival epithelial cells and human pulp fibroblasts following exposures to varying HEMA concentrations (albeit high e 0.1e10 mM) for 24 h showed an increase in reactive oxygen species (ROS) at 1.0 mM 5.0 mM, with subsequent decrease while GSH intra-cellular levels fell but only at 5e10 mM concentrations (Chang et al., 2005) . The relationship between GSH and ROS production may not be simple however, as indicated by a study of human THP-1 monocytes exposed to HEMA at concentrations up to 10 mM for 24 h (Noda et al., 2005) . Intracellular reduced (GSH) and oxidized (GSSG) decreased as exposure concentrations approached the TC50 for HEMA (10 mM). Unexpectedly, the GSH/GSSG ratio did not significantly change with exposure, suggesting some other reason for the depletion.
The products of direct metabolism of the lower alkyl methacrylates, both primary and secondary, as well as the indirect products such as ROS are all potential mediators of the genotoxicity reviewed below.
Genotoxicity versus mutagenicity
Genotoxicity is a category of toxicity that includes but is not limited to mutagenicity. It is the mutations that are the heritable changes in the DNA nucleotide sequence that change information content. Mutagens do not directly cause mutations; they cause DNA damage, which is not the same as changes in nucleotide sequence. DNA damage can be and usually is repaired without progression to mutation. If there is no or inadequate repair, cells may tolerate the damage, may die due to the inability of the cell to replicate past the DNA damage or may suffer a mutation. DNA damage may be detected directly, e.g. DNA adducts, DNA strand breaks) or indirectly (DNA repair, sister chromatid exchanges. Many of the studies reviewed here measured genotoxicity as reflected in DNA damage end-points e not mutations.
Scope of review
The compounds reviewed here are the seven mono-functional alkyl esters of methacrylic acid, i.e. MMA, ethyl methacrylate (EMA), HEMA, n-, i-and t-butyl methacrylate (n-BMA, i-BMA and t-BMA, respectively) and EHMA, as well as MAA itself, the acyl component common to all (Table 1 ). The esters have the general formula C4H3O2R, where R is the organic radical comprising from one to eight carbons.
A category approach is used in this review, an approach justified by similarities in chemical structure, chemical and biological reactivity, metabolism and common metabolic products of the group (OECD, 2004) (Fig. 1, Table 2 ). The genotoxicity of each compound is reviewed with data gaps inferred by read-across (Patlewicz et al., 2013) .
This review is concerned only with MAA and its short-chain alkyl esters e not with acrylic acid (AA) and its alkyl esters. MAA and its alkyl esters differ from AA and its alkyl esters in that the methacrylates have a methyl group adjacent to the double bond in the acyl component, thus hindering nucleophile addition at this site (Osman et al., 1989) . This addition has been correlated with a decrease in both cytotoxicity and genotoxicity of the methacrylates compared to the acrylates (Moore et al., 1988; Dearfield et al., 1989; Yoshii, 1997) .
This review describes in detail the genotoxicity of the lower alkyl methacrylates as a progression of events that, in the aggregate, defines the mutagenic process. As the carcinogenic potential of the most abundant of these methacrylates, i.e. MMA, has been well characterized, this will allow a juxtaposition of genotoxicity and carcinogenicity as an example of how different events in the mutagenic process may or may not predict carcinogenicity.
Material and methods

Literature review
Studies included in this review were identified using the US National Library of Medicine's PubMed database, as well as Google and Google Scholar as sources for the published literature. There was no time limit imposed on these searches. These data bases were interrogated using the key words genotoxicity, mutagenicity, carcinogenicity and metabolism with reference to each of the methacrylates of interest. Relevant papers that were cited in the identified literature were also retrieved. Foreign language reports were reviewed if a translation of either the full text or abstract was available. Normally unpublished studies would not be reviewed. However, in order to present all relevant studies, those for which a report is available were reviewed. No study of which we are aware has been omitted.
Order of presentation
The carcinogenicity studies of MMA are reviewed first as this is the only short chain alkyl ester of MAA so investigated. Cancer classifications by the various agencies are presented. The genotoxicity of MAA and its short term alkyl esters is then reviewed according to a scheme based on the biological significance of the various classes of endpoints studied. Endpoints that reflect DNA 
Results
Carcinogenicity
Although MAA and its lower chain esters have been shown to have irritating and possible skin sensitizing effects, the issue of most concern for human health is that of potential carcinogenicity. Concern about cancer in humans can be traced to an early report of an excess of colon cancer in workers engaged in acrylic sheet manufacture (Maher and DeFonso, 1984) . Exposures were to MMA and ethyl acrylate. These workers and several other cohorts have been studied extensively since this original report (Tomenson et al., 2005) and references therein). Colon cancer increases were not consistently observed in subsequent studies and analyses, although the cause of the increase in the original cohort, which occurred only in workers who experienced high concentration exposures during the 1930s and 1940s, is unexplained. Increases in other cancers in exposed workers were observed in some cohorts but did not appear related to MMA.
The widespread human exposure coupled with the finding of the early human epidemiological study lead to long term cancer bioassays in animals. MMA, which was the methacrylate of concern in the original colon cancer study, was tested in rats, mice, and golden hamsters. In the first study, MMA was administered by inhalation to F-344 rats at concentrations up to 1000 ppm (males) or 500 ppm (females) and to B6C3F1 mice at concentrations up to 1000 ppm (both sexes) for 102 weeks (NTP, 1986; Chan et al., 1988) . These doses were based on excessive toxicities including deaths at higher concentrations as determined by 14 day studies in both species. There were no increases in tumor incidences in either sex of either species. Subsequently, MMA was administered by inhalation to male and female F344 rats for 24 months and to male and female Golden Hamsters at concentrations up to 400 ppm for 18 months (Lomax et al., 1997) . As in the first study, there were no increases in tumor incidences in either sex of either species.
Several agencies have offered their assessment of MMA's carcinogenicity. National Toxicology Program: "Not classifiable as a carcinogen" (NTP, 1986) International Agency for Cancer Research: "Evidence supporting lack of carcinogenicity in experimental animals; inadequate evidence for carcinogenicity in humans; Category 3" (IARC, 1994) . U.S. Environmental Protection Agency: "Not likely to be carcinogenic in humans" (EPA, 1998) . European Centre for Ecotoxicology and Toxicology: Joint Assessment of Commodity Chemicals: "MMA shows no carcinogenic potential in animals. MMA does not present a carcinogenic hazard to man." (ECETOC, 1995) European Union Risk Assessment Report: "There is no relevant concern on carcinogenicity in humans and animals" (EU, 2002) .
Genotoxicity
The genotoxicity of the lower alkyl methacrylates has been reviewed on several occasions, with the latest overview being in 2008 (Zeiger et al., 1987 , EU, 2002 , Johannsen et al., 2008) . However, there have been more recent studies, especially of HEMA in the dental literature. These newer studies have assessed additional genotoxic endpoints, relating them to metabolic pathways that can give rise to reactive intermediates and oxidative DNA damage. Results of all genotoxicity studies are reviewed here e the newer as well as the older previously reviewed studies e to present and collect a current complete view of the genotoxicity of the lower methacrylates in one place. The genotoxicity results reported below are summarized in Table 3 .
3.2.1. Experimental studies 3.2.1.1. DNA adducts e due to direct reaction with DNA or to secondary oxidative DNA damage. The only direct study of DNA adducts induced by methacrylates was a study in which MMA was incubated for 21 h with calf thymus DNA and adduct formation was measured by 32 P post-labeling (Chou et al., 1996) . No adducts were detected. When MMA was co-incubated with the known DNA reactive chemicals 1-nitropyrene or benzo [a]pyrene, DNA adduct formation by these two agents was inhibited compared to formation following incubation with either alone.
Although not a study of DNA adduct formation per se, DNA reactivity by MAA was shown in a DNA binding assay (Kubinski et al., 1981) . This assay apparently measures DNA-protein adducts bound to bacterial membranes by scintillation spectrometry (radiolabeled DNA added in the assay system). Incubation of bacteria with MAA at 50 or 500 mM concentration for 30 or 60 min was interpreted as positive. No reports of this assay being used in recent decades were found.
DNA adducts as indicators of oxidative DNA damage have been indirectly demonstrated by modified comet assays. HEMA at 5 and 10 mM concentrations for one hour induced oxidative DNA lesions in both human PBLs and A549 human lung cells in vitro as measured by increased DNA migration in endonuclease III (endo III) or formamidopyrimidine-DNA-glycosidase (Fpg) modified comet assays (Pawlowska et al., 2010) . Endo III lyses DNA oxidized pyrimidine sites while Fpg lyses preferentially at 7,8-dihydro-oxyguanine (8-oxy-dG) sites, although the specificities are not absolute (Smith, O'Donovan et al., 2006; Speit and Hartmann, 2006; Collins, 2009) . Positive results with Fpg comets were more pronounced than those with endo III comets in the study by Pawlowska et al. (2010) . As detected by these modified comet assays, the oxidative damage induced by 10 mM HEMA did not persist, apparently being repaired by 120 min. Hydrogen peroxide 20 mM for 10 min as the positive control gave positive results with both enzymes. This study was followed by an evaluation of both MAA and HEMA as inducers of oxidative damage in human gingival fibroblasts in vitro, with the former studied as the metabolic intermediate of the latter (Szczepanska et al., 2012) . As in the first study, both MAA and HEMA at 5 mM concentration induced DNA damage as measured by these modified comet assays in human gingival fibroblasts following 6 h incubations. Hydrogen peroxide was again the positive control. Again, the MAA and HEMA induced oxidative damage adducts did not persist longer than 120 min. As assessed in these assays, HEMA produced more oxidative DNA damage than did MAA.
3.2.1.2. In vitro studies: DNA damage endpoints reflecting changes resulting from DNA interactions with methacrylates or oxidative stress. DNA damage in vitro indicate indicates that a chemical directly applied at any exposure concentration has the potential for damaging the genetic material. Genotoxicity at this level does not indicate if the damage will progress to mutation. DNA damage endpoints include bacterial or cellular responses to DNA damage, DNA strand breaks and SCEs.
3.2.1.2.1. Bacterial or cellular responses. Two screening tests were used to determine if HEMA damaged DNA in either bacterial and/or mammalian cells (Heil et al., 1996) . In the first, HEMA was applied to a Salmonella tester strain (TA 1535/pSK 1002) at concentrations ranging from 0.2 to 40 mM for 2 h with the SOS response (indicating DNA damage) being measured colormetrically (Oda et al., 1985; Heil et al., 1996) . Results were negative at all concentrations tested. In the second screening test, the inhibition of DNA synthesis in human HeLa cells exposed to HEMA at these same concentrations for 90 min was determined by BrdU incorporation. Results were also negative at all concentrations (Heil et al., 1996) . 3.2.1.2.2. DNA strand breaks. DNA strand breaks as measures of DNA damage were determined for MAA and HEMA in several studies. The alkaline comet assay was employed in a study of DNA single strand breaks (SSBs) (or alkali labile incomplete excision repair sites) of human PBLs (non-stimulated) exposed in vitro to HEMA at concentrations ranging from 10 À8 to 10 À2 M for 60 min (Kleinsasser et al., 2004) . Results were negative at concentrations of 10 À8 and 10 À7 M but became positive at 10 À6 M and higher as assessed by increased DNA migration with the greatest effect at 2.5 Â 10 À2 M. Cells maintained 84% viability determined by trypan blue staining. In a second study using the alkaline comet assay by these same investigators, both human PBLs (non-stimulated) and salivary gland tissue (from surgical removals) were exposed in vitro to HEMA at concentrations ranging from 10 À7 to 2.5 Â 10 À2 M (Kleinsasser et al., 2006) . Results for PBLs were essentially as in the original study, with effect first seen at a concentration of 10 À5 M and greatest at 2.5 Â 10 À2 M. Salivary gland tissue was somewhat more resistant, with a positive effect first observed at 10 À3 M and greatest effect at 2.5 Â 10 À2 M. Cell viabilities were in the range of 70% determined by trypan blue staining. Although the extent of DNA migration following exposure to HEMA was greater in salivary gland tissue than in PBLs, suggesting a greater effect, the response in both tissues was only 8e10% of that seen in the MNNG positive control, which is a strong DNA breaking agent. DNA SSB (or alkali labile sites) and double strand breaks (DSBs) were both later studied in human PBLs in vitro (non-stimulated) employing different versions of the comet assay and in a DNA plasmid. Exposures to HEMA at concentrations ranging from 1.0 to 10.0 mM for the cells (lower to study repair) and 0.3e10 mM for the plasmid were for one hour (Pawlowska et al., 2010) . In addition, cell cycle changes were also determined in A549 human lung cells in this study. There was no effect on the DNA plasmid at any HEMA concentration (assessed by plasmid relaxation) even though this material was sensitive to DNA breakage induced by hydrogen peroxide. There was a concentration dependent increase in SSBs as assessed by increased DNA migration in the alkaline comet assay but no increase in DSBs as assessed in the neutral comet assay. Lack of DSB induction was confirmed by pulsed field electrophoresis. HEMA induced apoptosis in the PBLs following 6 h incubations and caused a cell cycle arrest in A549 cells at the G0/G1 checkpoint. As was also observed for the strand breaks detected by modified comets (see above oxidative DNA damage) the SSBs (or alkali labile sites) in this study were repaired by 120 min. Furthermore, the increased DNA migration in the alkaline comet assays was decreased by spin traps (to remove ROS), vitamin C and the antioxidant methylglycol chitosan suggesting that the effects observed were due at least in part to oxidative DNA damage.
A different assay system was used to demonstrate the induction of DNA DSB in human gingival fibroblasts exposed in vitro to HEMA at concentrations ranging from 0.01 to 100 mM (Urcan et al., 2010) . After determining the half maximum effect concentration for viability (EC50 ¼ 11.2 mM), cells were exposed to 1/10, 1/3 and 1.0 Â EC50 concentrations of HEMA for 6 h and analyzed for gH2AX foci. The gH2AX focus assay detects the ATM dependent phosphorylation of histone A2AX at the terminal serine 139, which is one of the earliest cellular responses to DNA DSBs (Rogakou et al., 1999) .
HEMA induced gH2AX foci significantly above background at all concentrations tested indicating induction of DNA DSBs, a finding in contrast to that of Pawlowska et al. (2010) , (above) although the detection methods were quite different in the two studies and the target cells, i.e. fibroblasts, were proliferating in vitro (with DNA synthesis) while the non-stimulated PBLs were quiescent (in G0).
The induction of gH2AX and other phosphorylated signaling proteins of the DNA damage response were again used as an indirect indicators of HEMA induced DSBs in a study in which BEAS-2B human lung cells were exposed at concentrations ranging from 0.5 to 4.0 mM for 24 h (Ansteinsson et al., 2011) . Also measured in this study were inductions of SSBs as reflected in the alkaline comet assay, cell proliferation and cell cycle changes, cell death and apoptosis (TUNEL assay), ROS production by fluorescent probe and GSH levels. Cell necrosis and apoptosis were determined by nuclear fluorescence microscopy. Increases in gH2AX, phospho-Chk2 and p53 as determined by both Western blotting and cytometry were observed at 3.6 and 5.4 mM HEMA with further increases with duration of exposure. Increased DNA migration in the alkaline comet assay was seen at 5.4 and 8.1 mM HEMA indicating induction of DNA SSBs. Cell death occurred at 2 and 4.0 mM exposures, accumulation of cells in early S-phase was seen at 5.4 mM and apoptosis was observed at 5.0 mM, becoming significant at 7.5 mM. ROS production was significantly increased after 2e6 h of exposure to 5.4 mM HEMA, then returned to normal while significant GSH reduction was seen only after 6 h exposure at that concentration, after which it also returned to baseline. Despite the increases in ROS production and decrease in GSH, the cell cycle effects as noted were not countered by the anti-oxidant trolox.
The most recent study of SSBs and DSBs involved exposures of human gingival fibroblasts or to plasmid DNA in vitro to MAA or HEMA at concentrations ranging from 1 to 10 mM for 6 h (Szczepanska et al., 2012) . In addition to SSBs and DSBs, apoptotic cell death and cell cycle perturbations were measured. Cell viability was measured by staining and flow cytometry. As described above, production of oxidative DNA damage by these two agents was also measured in this study. Neither MAA nor HEMA had any effect on plasmid DNA at any concentration. By contrast, both MAA and HEMA induced SSBs in the gingival fibroblasts as indicated by increased DNA migration in the alkaline comet assay beginning at the lowest concentration tested (<1.0 mM) and increasing in a dose dependent manner. There was no difference in efficiency of induction by these two agents. Both MAA and HEMA also induced DSBs in the gingival fibroblasts as indicated by increased DNA migration in the neutral comet assay, again beginning at 1.0 mM and increasing with dose. Although HEMA had a greater effect in this regard than did MAA, the difference was not significant. The ability of both MAA and HEMA to induce DSBs in the gingival fibroblasts was confirmed by increases in gH2AX (determined by immunofluorescence) production in the cells at exposures to 10 mM of either agent. However, in this regard, HEMA was significantly more efficient than was MAA on a molar concentration basis. Both MAA and HEMA significantly increased rates of apoptosis beginning at 0.5 mM concentrations and increasing in a dose dependent manner. There was no difference in efficiency of the two agents in this regard. Both MAA and HEMA perturbed cell cycle kinetics, decreasing S-phase cells and increasing G0/G1 cells at 0.5 mM concentration and reversing this, with an increase in Sphase and decrease in G0/G1 phase cells at 1.0 mM concentrations. There was no difference in the degree of cell cycle perturbations induced by the two agents.
3.2.1.2.3. SCE as indicators of DNA damage. Sister chromatid exchanges (SCEs) are indirect manifestations of DNA damage but do not alter genetic information content (Wilson and Thompson, 2007) . They are of uncertain biological significance (Bonassi et al., 2004) .
SCEs as indicators of DNA damage were assessed in studies of MMA and EMA. In the first MMA study, stimulated human PBLs were incubated in vitro with MMA at various concentrations and analyzed for induction of SCEs (Cannas et al., 1987) . There was no significant induction over background. As this study is available only in abstract, the MMA concentrations are unknown and it is assumed that conditions and time of assay are the same as in the later study by these same investigators. In the second study by this group, human PBLs (stimulated by phytogemagglutinin [PHA]) were incubated with solid spherical samples (10 mm, 0.6 g) of polymethyl methacrylate (PMMA) added prior to PHA stimulation and present throughout a 72 h culture period (Bigatti et al., 1989) . SCEs were determined by standard methods. The solid PMMA spheres contained from 2 to 5% non-polymerized MMA which is the material tested in this study. As in the first study, there was no significant induction of SCEs over background.
MMA's ability to induce SCEs in vitro was also assessed in continuously dividing cells. CHO cells were incubated with MMA at various concentrations added at the onset of culture with SCEs being determined approximately 29 or >29 h later, depending on growth delay (Anderson et al., 1990) . External metabolic activation (liver S9 fraction) was added. MMA induced SCEs over background with or without S9. The lowest effective dose (LED) without S9 was 16 mg/ml (0.16 mM); with S9 it was 1600 mg/ml (160 mM). Growth inhibition was noted in the absence of S9. Medium pH was monitored and maintained at the physiological level.
Different results were found for EMA. CHO cells were incubated with EMA for 26 h at concentrations ranging from 50 mg/ml (0.44 mM) to 1600 mg/ml (14 mM) with our without S9 (NTP, 1985) .
SCEs determined at 28 h by standard methods did not increase over background at any concentration in the absence of S9 but were significantly increased at only the highest concentration (weak positive) in the presence of S9. There was no mention of pH. MAA was inactive in three Salmonella reverse mutation assays (Hachitani et al., 1981; Querens et al., 1981) [cited in (Johannsen et al., 2008) ]; (Haworth et al., 1983) . In the first, Tester strains TA 1535, 1537, 1538, 98 and 100 were used; details are unknown for the second while the third employed the pre-incubation protocol with tester strains TA1535, 1537, 98 and 100. Studies in TA strains 100 and 1535 assess base-substitution mutations while those in TA strains 98, 1537 and 1538 all assess frame shift mutations (Mortelmans and Zeiger, 2000) . All of the tester strains studied record mutations as G-C base pairs.
Nine reports of MMA mutagenicity studies that employed the standard Salmonella reverse mutation assay have been identified (Barsky, 1975; Sippel, 1979; Lijinsky and Andrews, 1980; Hachitani et al., 1981; Waegemaekers and Bensink, 1984; Zeiger et al., 1987; Zeiger, 1990; Schweikl et al., 1994; Schweikl et al., 1998) . In the aggregate, the above listed tester strains plus TA 102, 104 were employed. Strains TA 102 and 104 assess base substitution mutations at T-A base pairs (Mortelmans and Zeiger, 2000) . Doses of MMA up to 12.5 mg/plate or 2.5% v/v were used in plate assays and 25 mM in suspension assays. Two of the reports gave results of two independent negative tests (Zeiger et al., 1987; Zeiger, 1990) . Eight of the nine publications reported negative result for mutagenicity. One early report stated that MMA gave a marginal but statistically significant positive response in tester strain TA 1535 (2.5% v/v maximum dose) with but not without S9 when the plate assay was used and a marginal but statistically significant positive response (25 mM maximum dose) in tester strain TA 100 with S9 in the suspension assay (Sippel, 1979) . These marginally positive responses however, were not confirmed in the several negative subsequent studies, including a study in TA 100 with and without S9 (50 mM dose) using the suspension assay (Waegemaekers and Bensink, 1984) .
Two non-standard Salmonella assays were also used to study MMA's mutagenicity. Strain YG7108pin3ERb5 containing a transfected plasmid with DNA that encodes the complete electron reductase chain and p450 enzymes also gave negative results for MMA at concentrations up to 5 mg/plate or toxicity (Emmert et al., 2006) . Strain YG7 108, the parent for YG7 108pinERb5, is a derivative of strain TA 1535 that assesses base substitution mutations at G-C base pairs (Kushida et al., 2000) . However, MMA at a concentration of 34 mM and greater did induce mutations to 8-azaguanine resistance in Salmonella strain TM677 (Poss et al., 1979) . Unlike the standard Salmonella reverse mutation assays, mutation to 8-azaguanine resistance is a forward mutation that inactivates function of the bacterial guanine-xanthine phosphoribosyltransferase (gpt) (Skopek et al., 1978) . Although the forward mutation assay and standard reverse mutation assay systems have proven to be equally sensitive for detecting chemical mutagens when they are both responsive, the forward mutation assay provides a larger target for mutation, i.e. the gpt gene is approximately 450 bp in size, thereby allowing detection of small deletion mutations (Skopek et al., 1978; Matsui et al., 1996) .
Two studies of reverse mutations in standard Salmonella assays evaluated EMA's mutagenicity (Waegemaekers and Bensink, 1984; Zeiger et al., 1987) . Employing the tester strains and assay conditions described above, the results were negative with or without S9 in both. Five reports of HEMA mutagenicity studies that employed standard Salmonella reverse mutation assays have been identified (Carpanini_FMB, 1981, Waegemaekers and Bensink, 1984; Schweikl et al., 1994; Hatano_Research_Institute, 1997 , Schweikl et al., 1998 . Again, employing the tester strains and assay conditions previously noted, all five studies were reported as negative with or without S9.
An initial incomplete screening Salmonella reverse mutation assay employing only tester strain TA 1538 was reported as positive for n-BMA in presence of S9 (Anonymous, 1990) . Tester strain TA 1538 carries the D3052 mutant allele that is reverted to wild-type by a frame shift mutation at G-C base pairs (Mortelmans and Zeiger, 2000) . The screening assay employed pre-incubation n-BMA doses up to 10.0 ml/plate which were subsequently found to be extremely toxic. This screening study was followed up by a full standard Salmonella reverse mutation that employed tester strains TA 1535, 1537, 98 and 100 as well as TA 1538 and pre-incubation n-BMA doses up to 0.3 ml/plate, the highest dose being only moderately toxic (Anonymous, 1991) . This full study was negative for mutation with our without S9 in any tester strain.
There have been four additional studies of n-BMA in standard Salmonella reverse mutation assays in which the full complement of tester strains as indicated were employed (Waegemaekers and Bensink, 1984; Zeiger et al., 1987; Anonymous, 1989; MHW, 1998a, b) . The last study also employed E. coliWP2uvrA as a tester organism. E. coli WP2 tester strains assess base substitution mutations at A-T base pairs (Blanco et al., 1998) . Results over a wide-range of doses were negative in all with or without S9. t-BMA was also tested in this last referenced study. Results were negative with or without S9. A negative Salmonella reverse mutation study of i-BMA at concentrations ranging from 100 to 10,000 mg/plate with or without S9 in tester strains TA 1535, 1537,98 and 100 was reported in a REACH dossier (ECHA).
Two bacterial mutagenicity studies were identified for EHMA (Molinier, 1994; MHW, 1998a, b) . The first employed Salmonella tester strains TA1535, 1537, 98, 100, 102 in a plate incorporation assay; the second Salmonella tester strains TA 1535, 1537, 98, 100 and E. coli WP2uvrA, also in a plate incorporation assay. Both showed EHMA to be negative for mutations in bacteria with or without S9 over a wide range of doses.
3.2.1.3.2. Mutations in eukaryotic microorganisms. Eukaryotic microorganisms as mutation target cells differ from bacteria in that the DNA in eukaryotic cells has chromosome structure. Only MMA has been studied in these systems (Jiang et al., 1989; Wang and Jiang, 1990 ). In the first study, chromosome loss was reported in the yeast Saccharomyces cerevisiae after MMA incubation using an interrupted procedure that varied temperature during exposure; in the second study, MMA induced chromosome segregation defects in this same organism without effects on mitotic crossing-over (exchange of genetic material among homologous chromosomes). Details are few as both studies are reported in abstracts. However, there was no external metabolic activation indicating that the yeast were intrinsically capable of metabolism.
3.2.1.3.3. Mutations in mammalian cells. Mutations in vitro in mammalian cells, including human, are considered to be more relevant for assessing risks to humans than are such changes in the cells of lower organisms. Mutations in these systems may be at the gene or chromosome level, i.e. CA or MN.
Early studies in mammalian cells frequently employed concentrations of test materials greater than those recommended in current guidelines. The most recent OECD guidelines recommend that results for gene mutations not be considered at concentrations of test materials that yield cell survivals less than 10% (90% kill) and that those at concentrations yielding between 10% and 20% survival be considered with caution (OECD, 2016a,b) . For chromosome level mutations, both CA and MN, the greatest concentration for reliable evaluation of positive results is given as that yielding 45% survival (55% kill) (OECD, 2016c,d) . The interpretations (positive or negative) presented below for the several studies are those of the respective investigators. However, cell survivals where given should be taken into consideration by the reader. Many of the studies deemed positive by the investigators would likely not be so according to current guidelines.
3.2.1.3.3.1. Gene mutations There have been six reports of MMA induced gene mutations at the Tk locus in mouse lymphoma L5178Y ± cells, all of which have been positive (Cifone, 1985; Amtower et al., 1986; Moore et al., 1988; Doerr et al., 1989; Moore and Doerr, 1990; Myhr et al., 1990) . L5178Y mouse lymphoma cells are sensitive to mutation induction for two reasons. First, these cells have a defect in the p53 tumor suppressor gene (Clark et al., 1998) . Second, this line was derived from a parental line that was sensitive to oxidative stress because of a relative deficiency of antioxidant defenses and high iron content (Alexander, 1961; Bouzyk et al., 2000; Szumiel, 2005) . Two kinds of Tk À/À mutant colonies, i.e. large and small or slow growing, may be observed when using the L5178Y Tk ± assay (Moore et al., 1988) . The former will be the predominant type of mutant for chemicals that induce primarily point mutations (base changes) in the Tk gene while the latter (small colonies) will be the predominant type of mutant for chemicals that are primarily clastogenic. Adequate testing using the L5178Y Tk ± assay requires enumeration of both large and small colonies to differentiate gene point mutations from chromosome level changes (clastogenicity).
In the earliest of the studies in L5178Y Tk ± cells, MMA at concentrations of 100e300 ml/ml (0.9e2.7 mM) significantly increased the frequency of Tk-/-mutations in a dose dependent manner but only in the presence of S9 external metabolic activation (Cifone, 1985) . There was moderate to major toxicity determined by relative cloning efficiencies at these doses. However, increases in mutant frequencies over background were seen at relative cloning efficiencies above 20% in cultures containing S9. It was stated that the medium began to become yellow at higher (4.7 and 9.4 mM) MMA concentrations indicating acidity. Colony size was not mentioned in this early report. Somewhat later, Amtower et al. (1986) reported MMA induction of Tk-/-mutations beginning at a concentration of 2.0 mM, again only in the presence of S9. Cytotoxicity was not reported. It was noted that most of the mutants were slow growing indicating clastogenicity. A study in the absence of S9 also reported MMA to be mutagenic to the L5178Y cells, but at a higher concentration that than reported earlier, i.e. 30 mM permitting 11% survival determined by cloning efficiency (Moore et al., 1988; Dearfield et al., 1989) . Most of the mutants were slow growing. Somewhat later this same group reported again that MMA induced Tk-/-mutations without S9 in these same cells at concentrations from 10 to 30 mM, permitting from 53 to 11% survival, respectively, again determined by cloning efficiency . Fully 87% of the mutants were small colony, indicating slow growth and clastogenicity.
There are two additional reports of MMA induced mutations in this system, with both being reviews of data determined by others or derived from earlier studies of the authors. (Moore and Doerr, 1990; Myhr et al., 1990) . A survey of many chemicals tested by the National Toxicology Program reported that MMA was positive at a concentration of 14 mM without S9 but the result was inconclusive in the presence of S9 (reviewed in Myhr et al., 1990) . Cell survival data were not provided. As in the other studies, the majority of the mutants were small colony. Moore and Doerr (1990) reviewed their earlier L5178Y MMA mutagenicity studies in terms of small versus large colony mutants finding that approximately 85% of the mutants were small colony, indicating slow growth and clastogenicity.
MMA was also evaluated in V79 cells for induction of gene mutations at the Hprt locus (Schweikl et al., 1998) . Unlike the Tk gene, which is autosomal, the Hprt gene is located on the X-chromosome in mammalian cells, is therefore hemizygous and considered less able than Tk to survive large deletions. Incubation of V79 cells with 10 or 20 mM MMA for 24 h in the absence of S9 produced very small increases in Hprt mutations without serious toxicity determined by cell counts post treatment and relative cloning efficiency (Schweikl et al., 1998) . Although cell survivals were greater than 20%, the authors refrained from calling this response unequivocally positive.
The other methacrylates reviewed here have also been studied for induction of gene mutations in mammalian cells. EMA gave a weakly positive response in L5178Y cells at concentrations up to approximately 20 mM associated with severe toxicity determined by relative cloning efficiencies (Moore et al., 1988) . Positive responses were reported for concentrations that yielded less than 10% cell survival. Colony size was reportedly difficult to score because of toxicity. HEMA did not induce Hprt mutations in V79 cells without S9 at concentrations up to 5.0 mM, a concentration that yielded virtually no cell killing determined by relative cloning efficiency (Schweikl et al., 1998) . Most recently, EHMA was also studied in V79 cells (Harlan, 2008 (Heddle et al., 2011) . MN are either fragments of chromosomes or entire chromosomes that have been lost from the nucleus during cell division. For in vitro studies in cultured cells, their accurate scoring may employ a means for identifying the cells in which they arise, i.e. those that have undergone their first cell division after exposure to a test agent. This is achieved by blocking cytokinesis using cytochalasin B (cytochalasin block MN assay) resulting in bi-nucleate cells (OECD, 1997; 2010 , Fenech, 1998 , 2000 Heddle et al., 2011) .
As noted above, current OECD guidelines (OECD, 2016a, b, c, d , e) suggest that positive results in studies that yield cell survivals less than 45% may be artifacts and should be interpreted with caution. Some studies described here reported a positive result in studies where survival was less than 45% or was not reported or determined.
MMA at a concentrations up to 30 mM in the absence of S9 produced CA over background frequencies in L5178Y cells (Moore et al., 1988) . Cell survival could not be determined in that study. Later it was shown that MMA induced both CA and MN in L5178Y at these same concentrations in standard assays without S9 . However, positive responses were seen at exposure levels that gave less than 45% survival.
MMA also induced CA in CHO cells at concentrations (lowest effective dose [LED]) of 15 mM in the absence of S9 and 50 mM (weak positive) in the presence of S9 (Anderson et al., 1990) . Cell survival was not reported. By contrast, when tested in V79 cells, there was no clear dose-response increase in MN with MMA up to 2.0 mM in the absence of S9 (Schweikl et al., 2001 ). An increase in MN did occur in this study, but only at a clearly toxic MMA (reduced cell numbers on slides) concentration of 3.0 mM determined by dye exclusion.
EMA has been studied for its ability to induce CA in both CHO and L5178Y (NTP, 1985; Moore et al., 1988) . In the first, several NTP studies reported inconsistent results in CHO cells. In a preliminary trial, EMA at 4.4.mM in the absence of S9 failed to induce CA while at 8.0 mM in the presence of S9 a weak positive was seen. Even more inconsistent, at 131 mM concentration with or without S9 in this preliminary trial EMA gave a negative response. This preliminary study was followed by two additional trials at lower EMA concentrations (NTP, 1985) . In the first, EMA at 26 mM without S9 produced a weak (statistical only) response while 44 mM with S9 failed to elicit a response. A second trail with EMA at 44 mM with S9 did give a positive response, which was the conclusion of the overall study. Post treatment cell survivals were not determined. When later tested in L5178Y cells, EMA showed a weak positive induction of CA when tested a concentrations up to 18 mM in study (Moore et al., 1988) . Again, cell survivals were not determined. Both n-BMA and t-BMA have been studied for CA in CHL (MHW 1998b, MPA_(Methacrylate_Producers_Association) 1999). There was no induction of CA (neither structural nor polyploid) with n-BMA as concentrations up to 10 mM with or without S9. Cytotoxicity was not reported. However, t-BMA induced structural CA (clastogenesis) with an LED of 2.8 mM, but only in the absence of S9 (Moore et al., 1988) . Cytotoxicity was not determined.
A study of HEMA in CHL (Chinese Lung) cells showed induction of both structural (clastogenicity) and numerical (polyploidy) CA. Structural aberrations were induced at a concentration of 1.2 mM continuous treatment without S9 and at a concentration of 10.0 mM short term treatment with S9. Polyploidy was induced at a concentration of 2.5 mM short term treatment without S9 (OECD, 2001). Cell survival was not reported. HEMA was also positive for MN induction in three studies in V79 cells (Schweikl et al., 2001; Lee et al., 2006; Schweikl et al., 2007) ) In the first, HEMA induced MN in a dose dependent manner at concentrations up to 4.0 mM in the absence of S9 where cell survival was greater than 50% as determined by dye exclusion (Schweikl et al., 2001) . Of note, addition of S9 largely abolished this response. Somewhat later, HEMA was again shown to increase MN induction in V79 cells in a dose-dependent manner at concentrations up to 5.0 mM in the absence of S9 (Lee et al., 2006) . Cell viability was approximately 80% determined by flow cytometry. Co-incubation with the anti-oxidant N-acetylcystein (NAC) reduced but did not abolish this response and improved cell survival. In the latest study of HEMA in V79 cells, a significant increase in MN frequency over background occurred at 6.0 mM concentration exposure level, a concentration that allowed approximately 40% cell survival as measured by cell counting (Schweikl et al., 2007) . Co-cultivation with NAC abolished the significant increase in MN and allowed cell survival of approximately 80%. However, a significant increase of MN was seen with HEMA at 8.0 mM even in the presence of NAC. At this concentration with NAC, cell survival was approximately 60%.
No studies of chromosome mutational effects were discovered for i-BMA.
In a study in human PHA stimulated PBLs, EHMA at 0.3 mM concentration in the absence of S9 did not induce CA frequencies above background while, at 10 mM concentration, an inconsistent increase was seen (Covance, 1997) . The authors concluded however, that this study conducted at the limit of toxicity, determined by relative decrease in mitotic index, was negative for biologically significant increases in CA. EHMA clastogenicity was also evaluated in CHL cells by MHW Japan (MHW, 1998a, b) . There was no induction of CA (neither structural nor polyploid) at concentrations up to 0.4 mM without or with 25 mM with S9. Cell viability was not reported.
In a study similar to one of SCE induction described above (Bigatti et al., 1989) , human PBLs were incubated with PMMA particles of different weights (average 140 mg) and assessed at termination of cultures for MN induction (Bigatti et al., 1994) . Specific cytotoxicity is not given but it was stated that larger particles gave excessive toxicity. Positive induction of MN was observed. It was noted that the particles contained other substances known to be genotoxic. For this reason, it is difficult to ascribe this result to MMA.
3.2.1.4. In vivo studies: non mammalian species. In vivo tests in nonmammalian species assess toxico-kinetic and toxico-dynamic factors relevant to genotoxicity. However, such tests are not equivalent to in vivo studies in mammals.
3.2.1.4.1. Studies in non-mammalian somatic cells. Only HEMA has undergone in vivo genotoxicity testing in somatic cells of submammalian species. Fresh water clams were incubated for two hours with HEMA, after which DNA was extracted from the gills for alkaline elution analysis for DNA SSB (Heil et al., 1996) . The study was negative. Most recently, a study in Drosophila melanogaster that employed the somatic mutation and recombination test (SMART) to detect homologous recombination, point and chromosome mutations was performed (Arossi et al., 2010) . Drosophila larvae were incubated with HEMA at concentrations of 59 and 206 mM for 48 h, with the mutational phenotypic changes measured later in adult fly wings. Results were negative.
3.2.1.4.2. Studies in non-mammalian germ cells. MMA has also been tested in the sex-linked recessive lethal (SLRL) assay in Drosophila melanogaster (Foureman et al., 1994) and cited in (EFSA, 2010) . In this assay, male flies are exposed by inhalation and subsequently mated to genetically marked females. Lethality of males is determined by distorted sex ratio of offspring. The results were negative at male inhalation exposure doses of 1400 or 14,000 ppm.
3.2.1.5. In vivo studies in mammals: DNA damage. Studies of DNA damage induced in vivo in mammals demonstrates that the agents of concern reach the genetic material in intact mammals, depending on the route of administration. Although this damages the genetic material, it does not demonstrate that the damage progresses to mutation.
None of the agents covered in this review have been tested in vivo for DNA damage end-points.
3.2.1.6. In vivo studies in mammals: mutations. Among the genotoxicity tests, studies of mutations arising in vivo in mammals are of the greatest relevance for human cancer risk assessments in that they demonstrate an agent's ability to induce mutations when reaching genetic targets and, furthermore, that they reach these targets in vivo in species that share physiological features of humans. MMA, HEMA, n-BMA and t-BMA have all been studied for induction of chromosome level (CA or MN) mutations in mammals.
3.2.1.6.1. Studies in bone marrow cells. Several studies of bone marrow chromosome level mutations have been conducted, with early reports dating to 1976 (Anderson and Hodge, 1976) . Some of the earlier studies have been deemed as equivocal/unreliable (EU, 2002; Johannsen et al., 2008) . OECD has issued guidelines for in vivo chromosome studies in animals, beginning in 1984, with updates in 1997 and 2013 (OECD, 1984; OECD, 1997; 2010 , OECD, 2014 OECD, 2016e) . In this review, details of all known studies will be presented, even if only abstracts and/or translations are available, along with the authors' conclusion.
The earliest report of in vivo cytogenetic effects of MMA is of a study of inhalation exposures in rats at a range of concentrations up to 9000 ppm either once for 2-h or for five days (5 h/day) (Anderson and Richardson, 1976) . CA were assessed in bone marrow (BM) cells. The authors judged the study to be negative for the single dose and equivocal for the multiple dose portions as elevations over control were small and without a dose-related response. This study was followed by another inhalation study employing the same dosing schedule with MMA at exposure levels up to 1000 ppm (Anderson et al., 1979) . The authors again concluded that the single dose portion was negative for CA in BM cells but that the multiple-dose portion was equivocally positive. Details of the second study, which presumably apply also to the first, include a harvest time at 24 h, inclusion of chromosome "gaps" in the analysis and the scoring of 50 cells per animal. Current OECD guidelines specify 200 cells. Gaps are no longer considered to be biologically significant. Furthermore, there is no mention of laboratory historical negative control levels for CA, something that also is at odds with current guidelines. Although exclusion of gaps would probably have resulted in the multiple-dose portions of these studies also being reported as negative, these early studies do not meet current OECD guidelines for a valid study.
Two studies of MMA induced CA followed; both are reported in the Russian literature and available only in extended abstract/ translation (Fedyukovich et al., 1988; Fedyukovich and Ergova, 1991) . In the first, MMA was administered i.p to non-inbred rats at a dose of 0.9 g/kg which corresponded to ½ of the LD50 dose, with sacrifice for CA analysis in BM cells 24 h later (Fedyukovich et al., 1988) . Hydroquinone was also administered i.p. as a stabilizer. No increase in CA was reported after analysis of 50 BM cells per animal although there was an increase in polyploidy. In the second study, MMA was again administered by i.p injection at doses of 0.3, 0.9 or 1.3 g/kg (now stated to be ¼, 1/3 and ½ of LD50 doses) either once as an acute treatment or twice-weekly over eight weeks as a sub-acute treatment, with sacrifice at 24 h. One-hundred BM cells per animal were analyzed for CA (Fedyukovich and Ergova, 1991) . Results were negative for CA induction with acute treatment at the lowest MMA dose but positive for CA at this dose in the sub-acute treatment and, at the highest dose level, in both treatment regimens. Both structural abnormalities and polyploidy were observed. It is not known if chromosome gaps were scored in these studies. Again however, these studies do not meet the 2013 OECD for valid in vivo cytogenetic studies.
The above four studies have generally been considered as unreliable/equivocal by the European Union and others (EU, 2002; Johannsen et al., 2008) .
A fifth study of MMA's clastogenic effects exposed rats presumably by inhalation to concentrations up to 1000 ppm as a single treatment or for five hours/day for five days (Smith 1980 )and cited in (EPA, 1998) . Results are reported as negative/weak positive for CA in BM cells but few details are available. It is unknown if gaps were included in the count of aberrations.
Subsequent in vivo studies of MMA's cytogenetic effects have measured changes in MN frequencies in BM or BM derived cells. In the first, MAA was also evaluated (Hachiya et al., 1982) . In that study, MAA or MMA was administered to mice by gavage -MAA at doses from 62.5 to 250 mg/kg as a single dose or 125 mg/kg for four doses and MMA at doses from 1.13 to 4.52 g/kg as a single dose or 1.13 g/kg four doses. Eight to 10 thousand cells were scored per animal. Results were negative for induction of MN in BM polychromatic erythrocytes (MN-PCE) for both agents at all doses. There was only slight decrease of percent reticulocytes as a measure of BM toxicity raising concern as to adequacy of BM exposure.
An abstract in the Chinese literature reported that MMA failed to induce MN in rat bone marrow cells (Ouyang et al., 1989) . Unfortunately, no details were provided. Somewhat later, BM MN-PCE and MN-NCE (normochromatic erythrocytes, red blood cells to reflect chronic effects) were determined in mice 24, 48 or 72 h following an i.p. injection of 50 ml/kg body weight of an extract of one of three bone cement formulations (Jensen et al., 1991) . The extracts contained MMA at concentrations up to 1200 ppm; 1000 cells were scored per animal. Results were negative for both MN-PCE and MN-PCE for all extracts at all time points. BM toxicity as reflected by PCE/NCE ratios was minimal to non-existent.
The most recent study of MMA exposed rats by inhalation for eight hours in a single day or for a total of 40 h over a five day period, with sacrifice 24 h after exposure for assessment of MN in 2000 BM cells per animal (Araújo et al., 2013) . Exposure technique consisted of evaporation from a container in the cages that contained 10 ml MMA, estimating that evaporation of 0.5 ml/day resulted in a concentration in air of 150 ppm. The extended 40 h exposure was intended to simulate a 40 h human work week at a concentration 1.5 Â that allowable by the Brazilian Occupation and Health Safety rules. MMA did significantly induce MN in BM cells over control levels with the short interval exposure but not with the long term exposure. With only a single exposure concentration, dose-responses cannot be determined. Although the authors recognize that their finding is biologically unexplained (positive short term followed by negative long term), they speculate that stimulation of DNA repair blunts the response long-term.
HEMA, n-BMA, and i-BMA were each evaluated for MN induction in BM cells in vivo in single studies. Male rats exposed to HEMA orally at doses of 500, 1000 or 2000 mg/kg Â2 were sacrificed 24 h post exposure and BM MN (MN-PCE) were measured in 2000 PCE per dose (MHW Japan 2001; (Mitsubishi_Rayon_Co.L, 2001) . PCE/ NCE ratios determined cytotoxicity. The authors report compliance with OECD 474 and GLP standards. There were no increases in MN-PCE in any treatment group compared with the negative control while the positive control (cyclophosphamide) gave the expected significant increase. n-BMA at concentrations of 500, 1000 and 2000 mg/kg was administered i.p. to male and female mice with sacrifice 24 and 48 h post exposure for determination of BM MN (MN-PCE) induction in 2000 PCE (Ciliutti, 1999) . Five animals per sex per dose were scored. There was no significant increase in MN-PCE in either sex at any dose at any time point, with mild toxicity seen by PCE/MNC ratio. The authors state compliance with GLP standards. i-BMA was administered orally to male and female mice as a single one-time dose of 5000 mg/kg with sacrifice 24, 48 or 72 h later for determination of MN-PCE in 1000 BM cells (V€ olkner, 1989) . Five animals per sex per group were scored. There was no significant increase in MN-PCE in either sex at any dose level with mild toxicity as measured by PCE/NCE ratios.
3.2.1.6.2. Study in male germ cells. MMA's in vivo germ cell mutagenicity was determined in a Dominant Lethal Test in mice (Anderson and Hodge, 1976) . This test evaluates mutation induction, usually at the chromosome level, in sperm by assessing viability of embryos in subsequent matings. In this study, male mice were exposed by inhalation to MMA to doses of 100, 1000, or 9000 ppm six hours/day for five days, after which they were mated to females for five days. Following removal, the females were sacrificed 15 days later and products of conception analyzed. No effects were seen as regards number of early embryo deaths, mean number of early deaths per pregnancy or pre-implantation egg loss. This test result was negative indicating no in vivo germ cell mutagenesis. The cyclophosphamide control gave clearly positive results under the conditions of this test.
Human studies
Studies in humans may detect genotoxic events resulting from adverse environmental exposures. Although humans are the most relevant species for assessing genotoxicity as it relates to health risks, human studies are observational rather than experimental. The potential pitfall of observational studies is uncertainty as to exposure. Co-exposure to other chemicals, which are often not characterized, can confound interpretation. The inclusion of specific exposure biomarkers in a study modifies this concern.
Three studies in humans exposed to a methacrylate in industry or dental practice were identified (Marez et al., 1991; Seiji et al., 1994; Lamberti et al., 1998; Azhar et al., 2013) . Additional studies in the dental literature that report in vivo genotoxic events in humans attributed to dental restorative materials (amalgam or resin based restoratives) or bone cements are not reviewed here as these materials contain a variety of substances, some of which are genotoxic (Lamberti et al., 1998; Rogalewicz et al., 2006; Di Pietro, Visalli et al., 2008; Visalli et al., 2013) .
Thirty-one workers in four French industries engaged in production of MMA or poly-methyl methacrylate products were studied for SCE frequencies in PBLs (Marez et al., 1991) . MMA concentrations, measured as workplace levels in air differed among the industries ranging from 2.71 to 21.6 ppm means over an 8-h period. However, six workers were exposed to short term "peak" MMA levels, measured over one hour at 114e165 ppm means (two workers) or 360e400 ppm means (four workers) in two different plants. Overall ages were similar between controls and exposed workers. Overall, there was no increase in mean frequencies of SCE between the exposed and control groups. However, when comparing values for the six workers with high level peak MMA exposures, mean SCE frequencies and numbers of high frequency cells (HFCs) in this group were significantly higher than for either the control group or the remainder of the exposed workers. HFCs, defined as cells with a number of SCE greater than expected from the distribution of SCEs among cells for the group, may represent either exceptionally sensitive cells or long-lived cells with greater accumulation of SCEs over time. HFCs accounted for the increase in mean SCE frequencies in the peak worker group. Unfortunately, although the mean ages of groups studied were similar, nothing is said of the six workers with the greater SCE and HFC frequencies. SCE values increase with age in some studies.
Somewhat later, 38 workers engaged in poly-methyl methacrylate glass production in Japan were studied for CAs (100 cells per subject) and SCEs (20 cells per subject) in PBLs, with results compared to those in 11 age and sex matched controls (Seiji et al., 1994) . MMA vapor levels ranged from 0.9 to 71.9 ppm as measured by personal monitors; worker blood and urine methanol concentrations were consistent with levels of exposure. Overall, there was no difference in mean CA frequencies between the exposed and controls while SCE levels were higher in the exposed. This was attributed by the authors to higher ages in the exposed group. A nested study of non-smoking control and exposed workers, with the latter dichotomized into low and high exposure subgroups, showed no differences in either CA or SCE frequencies among the groups.
In the most recent human study, MN frequencies were assessed in buccal mucosa cells of 13 technicians working in a dental prosthesis laboratory for one year or more (10 males; 3 females) and compared with those from 14 non-workers (students and doctors, all male) (Azhar et al., 2013) . The age range of the entire study population was 21e40 years. Subjects were excluded from study for mouth wash use, oral lesions or dental prostheses. Exposures of technicians were said to be to MMA although no measurements were made. There was no significant difference in MN mean frequencies between the two groups. The authors state that this may be due to the protective measures taken by the technicians, i.e. face masks and gloves.
Summary of genotoxicity
The several genotoxicity studies reviewed here have evaluated responses in naked DNA, bacteria, eukaryotic micro-organisms and mammalian cells in vitro and in sub-mammalian and mammalian species in vivo, including human studies. Two general observations can be made from this data set.
First, when directly applied to test organisms in vitro, the lower methacrylates (and presumably MAA) can damage the DNA, inducing DNA SSB, DNA DSB, and gene and chromosome level mutations, the latter manifest as CA or MN. The DNA strand breaks are the likely molecular substrates of the gene and chromosome level mutations. Indications that the induced genetic changes are due to large scale alterations in the DNA is reflected at the gene level by results being almost universally negative for reverse mutations in bacteria but positive for TkÀ/À mutations in L5178Y mouse lymphoma cells detected primarily as slow growing mutants -a phenotype associated with the mutations being due large scale alterations. These in vitro mutational changes are usually seen only at high dose toxic concentrations of the agents e higher than those achieved in vivo. As noted above, several of the mutation studies do not meet current guidelines due to excessive toxicity.
Second, despite the findings in vitro, there is no convincing evidence that the lower methacrylates (or presumably MAA) can produce genotoxic effects in vivo in any test organism. All results in sub-mammalian species were reported as negative. The weight of evidence in mammals is also negative, with the scattering of equivocal/positive claims by authors of early studies likely resulting from scoring chromosome changes that are no longer thought to reflect aberrations. Furthermore, few of the early studies would be considered valid by OECD guidelines. Although only fragmentary, results of human studies do not suggest in vivo mutagenicity.
These observations may be reconciled by considering the potential genotoxic intermediates generated by metabolism of the lower methacrylates and the mutagenic mechanisms by which they damage DNA.
Discussion and conclusions
Potential genotoxic intermediates/mechanisms
Metabolic detoxification of the lower methacrylates generates several potentially genotoxic intermediates. The requirement for metabolism to produce genotoxicity is illustrated by the studies reviewed above in which neither MMA nor HEMA had an effect in vitro on naked plasmid DNA (Pawlowska et al., 2010; Szczepanska et al., 2012) .
Acidity
MAA per se and as an intermediate resulting from the primary carboxylesterase mediated detoxification metabolism of the lower methacrylates is a weak organic acid with pKa of 4.66 at 20 C. Its direct application to cells in vitro or at sites of contact in vivo may result in significant reduction of pH. A study of Tk mutations in MMA exposed L5178Y mouse lymphoma cells reviewed above commented that the culture medium turned yellow at a concentration of 4.7 mM and above, clearly indicating acidity (Cifone, 1985) . Many of the in vitro mutagenicity studies reviewed here employed concentrations in this range for the various methacrylates. As MAA is a metabolic intermediate produced in a one to one ratio by detoxification metabolism of all the lower methacrylates, the resulting acidity should be the same for all.
Genotoxic effects of low pH in cultured mammalian cells were reported three decades ago (Brusick, 1986; Cifone et al., 1987) . These effects include chromosome changes and gene mutations, i.e. Tk mutations in L5178Y mouse lymphoma cells. More recently, the issue of acidity induced chromosome aberrations has been studied in greater deal, demonstrating that it is a real phenomenon and differs from cell type to cell type (Morita et al., 1989; Morita et al., 1990; Meinti eres and Marzin, 2004) . Low pH is a well-documented cause of disparity between in vitro and in vivo genotoxicity test results.
4.1.2. Epoxides: 2,3-EpoxyMAA and 2,3-EpodioxyMMA As reviewed above, MAA and some methacrylates themselves may undergo mono-or di-oxygenase mediated oxidation to form epoxides. Epoxides are well known DNA reactive chemicals and form DNA adducts. Some DNA adducts by their very presence may cause errors of DNA replication resulting in a mutation unless efficiently repaired. These include those that alter DNA structure, prevent replication, or form at coding sites, i.e., O N3 of thymine (T) and are termed pro-mutagenic adducts. On the other hand, some adducts occurring on cyclic nitrogens in purines that are non-coding sites, e.g., N7G and N3A, usually do not produce mutations unless they distort DNA structure or convert to cyclic or ring-open structures (Singer and Grunberger, 1983) . These are termed non-pro-mutagenic adducts. Simple epoxides preferentially react at the N7 position of guanine (N7G adducts). The next most frequent site of adduction of these epoxides is at the N3 position of adenine (N3A adducts). It is estimated that 75e90% of adducts formed by these epoxides are N7G while an additional 4e8% are N3A adducts (Koskinen and Plna, 2000) . Both are non-pro-mutagenic adducts. In addition, N7G and N3A adducts are unstable and are usually removed by spontaneous depurination, leaving behind apurinic (AP) sites that are efficiently repaired (Boysen et al., 2009) . It has been estimated that there are approximately 30,000 abasic sites per mammalian cell at steady state, making them the most abundant kind of endogenous, background DNA damage (Swenberg et al., 2011) . The standard alkaline Comet assay reflects these lesions as well as DNA SSB. Although DNA synthesis across an abasic site may result in a mutation if there is insufficient time for closure of the site, this is not usually observed except at high and toxic concentrations of the offending agent (Boysen et al., 2009) .
Simple epoxides may produce other mutations at any of the base pairs, although these are in the minority. Some are promutagenic adducts inducing base-change mutations at either GC or AT base pairs. However, in the aggregate, all of the Salmonella reverse mutation assays reviewed above gave negative results for base change mutations. This was true also for tester strain YG7108pin3ERb5 which contains p450 enzymes capable of metabolizing test compounds (Emmert et al., 2006) . In the aggregate, the bacterial studies e all of which were negative -have evaluated base-changes at both base pairs.
Alcohols, formaldehyde
As discussed above, both alcohols and formaldehyde are produced by detoxification metabolism of the methacrylates, with formaldehyde itself being produced by MAA metabolism through the epoxidation pathway. These compounds are or may be further metabolized to potentially genotoxic agents. However, as regards formaldehyde, endogenous production provides a ubiquitous source in vivo under normal conditions. Endogenous blood concentrations of formaldehyde are in the range of 0.1 mM in rats, monkeys, and humans (Heck et al., 1982; Heck et al., 1985; Casanova et al., 1988) . Physiological intra-cellular formaldehyde concentrations are generally about half the blood concentrations (~0.050 mM); levels in nasal mucosa and liver are two-to four-fold blood levels (Heck and Casanova, 2004) . However, as noted above, the systemic distribution of HEMA in mice studied after either subcutaneous or gastric tube administration of 20 mM/kg radio-labeled material was rapid to all tissues, with tissue concentrations in the nM range after 24 h (Durner et al., 2009) . Furthermore, blood levels of MMA in patients exposed internally to contaminant monomers from the implanted prosthesis have shown the highest concentrations (~1.5 mg/ml ¼ 15 mM) in the first 10 min post-surgery, with rapid fall-off thereafter (Pfaffli and Svartling, 1985) . The internal levels of these methacrylates, which approximate internal formaldehyde levels resulting from further metabolism, are well below normal background levels. Presumably this applies to intermediates resulting from metabolism of the alcohols. On purely quantitative grounds therefore, concentrations of formaldehyde or alcohols derived from the methacrylates that are below the endogenous background level are unlikely to induce any additional systemic mutational events. Theoretically however, this may not apply to high concentration direct applications to local tissues at sites of contact in vivo.
Oxidative stress: reactive oxygen species (ROS)
The lower methacrylates have been shown to induce oxidative stress with attendant production of ROS and DNA damage in vitro (Walther et al., 2004; Chang et al., 2005; Spagnuolo, D'Anto et al., 2006; Paranjpe et al., 2007; Samuelsen et al., 2007; Paranjpe et al., 2008; Paranjpe et al., 2009; Szczepanska et al., 2012) ; ROS are clearly mutagenic chemicals. A great many DNA adducts affecting all four nucleobases are known to characterize oxidative DNA damage (reviewed in (Wallace, 2002; Cooke et al., 2003; Marnett et al., 2003) . Many are pro-mutagenic.
Oxidative lesions in DNA are continually being produced from endogenous sources in vivo, with estimates of the number of such lesions produced per cell per day ranging up to 1.5 Â 10 5 (Beckman and Ames, 1997) . Highly reactive carbonyls arising from lipid peroxidation resulting from oxidative stress also produce a variety of mutagenic DNA adducts (De Bont and van Larebeke, 2004; Bolt, 2012) . However, despite the genotoxicity shown by the lower methacrylates in the studies referenced above, and the potential mutagenicity of the products of oxidative stress, all of the methacrylate studies on oxidative DNA damage reviewed were in vitro and employed relatively high concentrations of the methacrylate tested (usually HEMA in the mM range). As noted for the alcohols/formaldehyde potential mutagenicity, these methacrylate concentrations are much higher than those that have been achieved in vivo. Again, on quantitative grounds, the lower methacrylates are unlikely to induce systemic mutations over background in vivo.
Conclusions
The genotoxicity profile of MAA and the lower methacrylates shows these compounds to be genotoxic in vitro where they have the capacity to induce DNA damage, gene level mutations associated with gross changes in the DNA as well as chromosome level mutations, i.e. CA and MN. Some of the positive results however, especially the mutations, have been seen in studies that do not meet current guidelines for chemical testing. Specifically, these events have been demonstrated on applications of high and usually toxic doses of the agent of concern. Despite this in vitro capacity, there is no convincing evidence that the lower methacrylates induce mutagenic events in vivo in any species tested.
This dichotomy of genotoxic effects may be explained by consideration of the potentially genotoxic agents responsible for the in vitro effects, all of which derive from detoxification metabolism. One, acidity, will be only an in vitro phenomenon seen with direct application to cells. Others are unlikely to be produced in sufficient amounts at systemic sites in vivo to induce genotoxicity. Formaldehyde, some of the organic acids and ROS are normally endogenously produced, with systemic levels achievable by exposures to the lower methacrylates being only a fraction of the levels already present.
The genotoxicity profile of the lower alkyl methacrylates can be viewed in the context of the carcinogenicity of these compounds as determined by studies of MMA. MMA and presumably the other methacrylates reviewed here are non-carcinogens in either animals or humans. Might this have been inferred from the genotoxicity test results of these compounds? The value of short term genotoxicity test results has been discussed and evaluated since the land-mark report of McCann et al. (1975) demonstrating that many carcinogens are mutagens. Schemes for using these tests have been debated ever since, with most agreeing that in vitro testing cannot fully predict carcinogenicity and that it is the mutational endpoints, i.e. gene or chromosome, that are of most value in predicting carcinogenicity (MacGregor et al., 2000; Bajpayee et al., 2005) and references therein.
It can be concluded that MAA and the group of lower methacrylates have all been evaluated for genotoxicity, even though every assay has not been performed on every agent. The similarities of structure, detoxification metabolic pathways and performance in the several tests in which several members of the group have been tested, indicate that the read-across approach to evaluating group genotoxicity is adequate for this appraisal.
The genotoxicity profile for the lower methacrylates is consistent with the earlier findings of long term carcinogenicity bioassays in animals, i.e. MMA as example of the group is not carcinogenic. Even though this group of agents has been termed high dose clastogens in vitro, they are not in vivo mutagens. The genotoxicity profile of the lower alkyl methacrylates predicts therefore, what has been concluded by the several agencies that have offered cancer classifications) (NTP, 1986; IARC, 1994; ECETOC, 1995; EPA, 1998; EU, 2002) .
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